Expand TIVC Menu
TIVC MENU

TIVC Latest Press Releases

-- March 25, 2026 --

Tivic Reports Full Year 2025 Results ACCESS Newswire 4:05 PM

-- March 24, 2026 --

Tivic Health CEO Letter to Shareholders ACCESS Newswire 9:31 AM

-- March 20, 2026 --

Tivic To Report 2025 Year-End Financial Results Via Conference Call and Webcast on March 25th at 1:30pm PT / 4:30pm ET ACCESS Newswire 3:35 PM

-- March 4, 2026 --

Biotech Veteran Michael K. Handley Named CEO of Tivic Health Systems to Spearhead Strategic Expansion in Biopharma ACCESS Newswire 8:30 AM

-- February 18, 2026 --

Tivic and BARDA Continue Discussions of Entolimod for Acute Radiation Syndrome on March 10 ACCESS Newswire 9:15 AM

-- January 28, 2026 --

Tivic, BARDA Discuss Entolimod(TM) for Acute Radiation Syndrome at TechWatch Meeting ACCESS Newswire 8:30 AM

-- January 26, 2026 --

Tivic to Showcase Strategic Pivot and Forward Outlook on Advancing Entolimod(TM) to Commercialization at DealFlow Discovery Conference ACCESS Newswire 10:10 AM

-- January 23, 2026 --

DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event ACCESS Newswire 2:51 PM

-- January 21, 2026 --

Presenting on Emerging Growth Conference 89 Day 2 on January 22; Register to live stream Globe Newswire 7:00 AM

-- January 20, 2026 --

Tivic CEO To Present at the Upcoming Emerging Growth's January 2026 Virtual Conference ACCESS Newswire 5:50 PM
Presenting on Emerging Growth Conference 89 Day 1 on January 21; Register to live stream Globe Newswire 7:00 AM

-- December 11, 2025 --

Tivic Acquires Ready-to-Scale cGMP Manufacturing and Development Assets to Accelerate Commercialization of Entolimod; Tivic Growth Backed By $90M+ Financing Package ACCESS Newswire 9:45 AM

-- November 18, 2025 --

Tivic Secures Barda Meeting for Entolimod(TM) for Acute Radiation Syndrome ACCESS Newswire 8:30 AM

-- November 14, 2025 --

Tivic Reports Third Quarter 2025 Financial Results ACCESS Newswire 4:30 PM

-- November 13, 2025 --

Tivic Health Reports Findings of Clinical Optimization Trial of Non-Invasive Cervical Vagus Nerve Stimulation (ncVNS) ACCESS Newswire 8:30 AM

-- November 10, 2025 --

Tivic Expands Intellectual Property Portfolio Business Wire 9:00 AM

-- November 6, 2025 --

Tivic Health to Report Third Quarter 2025 Financial Results on November 14th Via Conference Call and Webcast Business Wire 9:30 AM
Market Data Delayed 15 Minutes